Anal cancer rates soar since 1970s
Incidence of anal cancer have soared by almost 300% in the UK since the 1970s, new figures have shown. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - June 5, 2014 Category: Nursing Source Type: news
HPV behind dramatic rise in anal cancer rates
Incidence has risen by 374% in women, and 202% in men, since the 1970sRelated items from OnMedicaSocial media could help to cut STIsHighest-risk women least likely to have HPV jabTwo HPV jabs protect women from genital wartsOffer all young gay men HPV jab, say expertsExperts call for wider HPV vaccination (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 5, 2014 Category: UK Health Source Type: news
People With HIV at Increased Risk for Melanoma
It has been well documented that people with long-term HIV infection run a greater risk of developing a number of non-AIDS-defining cancers, among them anal cancer, Hodgkin's disease, and liver cancers. Over the course of recent years, researchers have been investigating the causes and incidences of these occurrences -- finding that, in some cancers, the risk is significantly higher, while others have either lower or no statistical difference risk at all....Read Full Post (Source: About AIDS / HIV)
Source: About AIDS / HIV - May 26, 2014 Category: Consumer Health News Source Type: news
New Stand Up To Cancer -- The Farrah Fawcett Foundation HPV Translational Research Team
(Entertainment Industry Foundation) The SU2C-Farrah Fawcett Foundation HPV Translational Research Team grant ($1.2 million over three years) for 'Therapeutic CD8 vaccines against conserved E7 HPV epitopes identified by MS,' focuses on patients with HPV-driven cancers (i.e., anal, cervical, head and neck) who relapse following initial therapy. Ellis L. Reinherz, M.D. and Robert I. Haddad, M.D. (Dana-Farber Institute) lead the team. The HPV and Anal Cancer Foundation supporting the team by making an additional gift to SU2C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 7, 2014 Category: Infectious Diseases Source Type: news
When You Feel Ashamed About Your Cancer...
In the public eye, all cancers are not judged equally. For that reason, it may be difficult for some cancer patients to talk about their disease, even to the point of not tell friends and family. Recently, I received an email from a reader who is battling anal cancer is feeling shame and embarrassment because of it. Her feelings of shame have been so strong that it has prevented her from adequately coping with the diagnosis....Read Full Post (Source: About.com Cancer)
Source: About.com Cancer - February 28, 2014 Category: Cancer & Oncology Source Type: news
Women's Lifestyle Choices, Clearance of Anal Infection With HPV16Women's Lifestyle Choices, Clearance of Anal Infection With HPV16
Most anal infections with human papillomavirus (HPV) clear within three years, but HPV16, which is linked to 90% of anal cancers, clears more slowly. Reuters Health Information (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - January 28, 2014 Category: OBGYN Tags: Infectious Diseases News Source Type: news
Neutralizing Antibodies to HPV in HIV-Positive MSMNeutralizing Antibodies to HPV in HIV-Positive MSM
How should previous exposure to HPV be measured in HIV-positive men to determine who might benefit from HPV vaccination for anal cancer? JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2014 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news
Four Ways Katie Couric Stacked The Deck Against Gardasil
This afternoon, Katie Couric ran a long segment on her daytime talk show, Katie, about what she called the ?controversy? over the vaccines against human papilloma virus, or HPV, an infection that causes cervical, throat, penile, and anal cancers. She featured one mother who says that Gardasil, the HPV vaccine (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
Increased anal cancer risk in men with both HIV and HPV
Human papillomavirus, or HPV, which can cause cervical cancer in women, is also known to cause anal cancer in both women and men. Now, a study led by researchers at the UCLA School of Nursing has found that older HIV-positive men who have sex with men are at higher risk of becoming infected with the HPVs that most often cause anal cancer.The researchers also report that smoking increases the risk of infection with specific types of HPV among both HIV-infected and uninfected older men by up to 20 percent. This is the first large U.S. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news
HIV plus HPV leads to increased anal cancer risk in men
This study highlights the benefit of adhering to HIV treatment, which among HIV-infected men who have sex with men, is important for cancer-prevention strategies," Wiley said.
The next step in this research is to begin looking at ways to develop better, more effective HPV infection–prevention strategies, including vaccination for age-eligible males and screening and treatment programs for high-risk men who have sex with men to prevent invasive cancers.
"Right now, we perform colonoscopies to prevent colon cancer, where 53 men per 100,000 are diagnosed annually," Wiley said. "Unfortunately, we do not p...
Source: UCLA Newsroom: Health Sciences - December 2, 2013 Category: Universities & Medical Training Source Type: news
HIV plus HPV leads to increased anal cancer risk in men
(University of California - Los Angeles) A study led by the UCLA School of Nursing found that men ages 40-69 who are having sex with other men, are HIV-infected and smoke are at a much higher risk of HPVs that most often cause anal cancer. This is the first large US study of a group of HIV-infected and uninfected men, over the age of 50. Many of these men were followed for more than 25 years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 2, 2013 Category: Global & Universal Source Type: news
HPV and Invasive Anal Cancers in the US Before VaccinesHPV and Invasive Anal Cancers in the US Before Vaccines
How prevalent is HPV in anal cancer patients, and could the vaccine help to prevent it from occuring? Journal of Lower Genital Tract Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
HPV vaccine could be offered to boys
"HPV vaccine could be given to boys as well as girls in UK," The Guardian reports.
It goes on to say that, "Government advisers are to consider whether the HPV vaccine, routinely offered to girls at the ages of 12 and 13 since 2008 to help protect them against cervical cancer, should also be offered to boys and some men".
The news appears to be based on draft minutes from the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI advises the government on how vaccinations may reduce health problems – and considers the evidence on factors such as the prevalence of diseases, and the safety ...
Source: NHS News Feed - November 29, 2013 Category: Consumer Health News Tags: Pregnancy/child Medication QA articles Cancer Source Type: news
UCSF scientist wins $89 million grant to study anal cancer in HIV-infected people
(University of California - San Francisco) A UC San Francisco investigator has won an eight-year grant from the National Cancer Institute for a major investigation into anal cancer, a debilitating and sometimes fatal disease largely concentrated among people with HIV. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 21, 2013 Category: Cancer & Oncology Source Type: news
“Anal Cancer Study Offers Hope of Treatment”,
This article discusses ongoing research regarding the use of HPV vaccines in prevention of anal cancer, as well as subsequent screening and other preventative routines and treatments in patients at higher risk of developing this rare form of cancer. This article features commentary from a physician at UCSF Helen Diller Family Comprehensive Cancer Center-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 19, 2013 Category: Cancer & Oncology Source Type: news
